Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Expert Opin Drug Deliv. 2010 Apr;7(4):403–427. doi: 10.1517/17425241003610633

Figure 1. Examples of therapeutic sites and targets accessible for intravascular drug delivery using RBC carriers.

Figure 1

Large, long-circulating RBC have an access and can deliver their cargo to targets in blood, including other blood cells (lymphocytes, white blood cells WBC), and pathogenic agents such as bacteria and toxins, to sites of vascular injury and endothelial cells lining vascular lumen (EC), and to diverse components of reticuloendothelial system (RES), such as macrophages in liver and spleen.